NARS COSMETICS
NARS Powder Foundation Sunscreen SPF12 / PA++
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
ACTIVE INGREDIENTS
OCTINOXATE 4.9%, TITANIUM DIOXIDE 6.6%
INACTIVE INGREDIENTS
NYLON-12, CALCIUM STEARATE, SILICA, DIMETHICONE, JOJOBA ALCOHOL, ISOPROPYL JOJOBATE, JOJOBA ESTERS, HYDROGENATED LECITHIN, TRIMETHYLSILOXYSILICATE, LAUROYL LYSINE, METHICONE, SORBITAN SESQUIOLEATE, TOCOPHEROL, BHT, METHYLPARABEN, PROPYLPARABEN, [+/- (MAY CONTAIN): MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491 CI 77492 CI 77499)],
WARNINGS
FOR EXTERNAL USE ONLY. WHEN USING THIS PRODUCT, AVOID CONTACT WITH EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. IF RASH OR IRRITATION DEVELOPS AND PERSISTS, DISCONTINUE USE AND CONTACT A DOCTOR. KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
NARS™
NARS COSMETICS NEW YORK, NY 10022 DIST. NEW YORK - SE PARIS - LONDON (UK) W2 5RH
MADE IN USA, MAKEUP YOUR MIND™ WWW.NARSCOSMETICS.COM
DERMATOLOGIST TESTED.
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - SIBERIA
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - PUNJAB
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - STROMBOLI
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - SYRACUSE
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - TAHOE
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - CÁDIZ
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - NEW ORLEANS
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - BENARES
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
PRINCIPAL DISPLAY PANEL - 0.4 Oz. Carton - DEAUVILLE
NARS
POWDER FOUNDATION
SPF 12 /
PA++
NET WT. 0.4 Oz. 12g e
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-013 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-013-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-014 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-014-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-015 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-015-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-016 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-016-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-017 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-017-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-018 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-018-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-019 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-019-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-020 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
12 in 1 TRAY |
|
|
|
2 |
NDC:13734-020-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2009-09-01 |
|
|
NARS
Octinoxate and Titanium dioxide POWDER
Product Information
|
|
Product Type
|
Human otc drug label |
Item Code (Source)
|
NDC:13734-021 |
|
Route of Administration
|
TOPICAL |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
|
Ingredient Name
|
Basis of Strength
|
Strength
|
|
OCTINOXATE OCTINOXATE |
|
137.2 mg
|
|
titanium dioxide |
|
184.8 mg
|
Packaging
|
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
|
1 |
|
2.8 in 1 TRAY |
|
|
|
2 |
NDC:13734-021-30 |
1 in 1 CARTON |
|
|
Marketing Information
|
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
|
part |
part352 |
2010-04-01 |
|
|
